About
Jeroen Aerssens, PhD, is Chief Development Officer at Rejuvenate Biomed, a Belgian clinical-stage biotech focused on therapeutics for age-related disease and healthy aging. He previously held senior scientific leadership roles across Johnson & Johnson companies including Janssen Pharmaceutica and Tibotec, with work spanning translational medicine, biomarkers, and clinical development. He is an active scientific contributor in geroscience and biopharma, with extensive publication and patent output and recent visibility at ARDD and ICFSR-related forums.
Areas of interest
longevityhealthy agingbiotechclinical developmenttranslational medicinebiomarkerssarcopeniainfectious diseasesneurosciencemetabolic diseasedrug discovery